Kathleen Stratton

Kathleen Stratton directs Innovate FDA, an initiative that promotes the development of safe and effective medical treatments by fostering and supporting improvements in the FDA’s scientific staff, tools, and regulatory processes.  Prior to her work at Pew, Stratton served as a scholar at the Institute of Medicine (IOM) of the National Academies of Science for 21 years where she had management and research responsibilities for projects in the areas of drug and vaccine safety, tobacco control, and public health preparedness. In October 2002, she was awarded the IOM’s Cecil Research Award for her sustained contributions to vaccine safety.

Stratton received an undergraduate degree in natural sciences from Johns Hopkins University, Baltimore, Maryland, and earned her Ph.D. in pharmacology and toxicology from the University of Maryland at Baltimore. She completed a postdoctoral research fellowship in the Department of Neuroscience at Johns Hopkins University School of Medicine.